Direct visualization of CHIP-mediated degradation of alpha-synuclein in vivo: implications for PD therapeutics.
Parkinson's disease is a neurodegenerative disorder characterized by Lewy bodies, a pathological hallmark comprised mostly of aggregated alpha synuclein. Accumulating evidence demonstrates the association of smaller oligomeric aggregates to disease etiology and many therapeutic approaches are a...
Guardado en:
Autores principales: | Hemi Dimant, Liya Zhu, Laura N Kibuuka, Zhanyun Fan, Bradley T Hyman, Pamela J McLean |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dee3e3b4dd7e4f65acf6ea5d3b17cf92 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro
por: Gessica Sala, et al.
Publicado: (2021) -
Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption
por: Iosif Pediaditakis, et al.
Publicado: (2021) -
Author Correction: Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro
por: Gessica Sala, et al.
Publicado: (2021) -
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
por: Rachel Kelly, et al.
Publicado: (2021) -
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
por: Caitriona McLean, et al.
Publicado: (2009)